Sinopharm Group Co. Ltd. (1099.HK)

19,620 +0,200 (+1,03%) Börsenschluss: 04:08PM HKT

Sinopharm Group Co. Ltd.

Sinopharm Group Building
No. 385, East Longhua Road Huangpu District
Shanghai 200023
China
86 21 2305 2666
https://www.sinopharmgroup.com.cn

Sektor(en): Healthcare
Branche: Medical Distribution
Vollzeitmitarbeiter: 115.959

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Qingming Yu	Executive Chairman of the Board	7,01M	N/A	1964
Mr. Yong Liu	President & Executive Director	6,77M	N/A	1969
Ms. Xiaojuan Li	Chief Financial Officer	N/A	N/A	1976
Mr. Yijian Wu	Secretary to the Board, Company Secretary & Authorised Representative	N/A	N/A	1970

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in HKD.

Beschreibung

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Corporate Governance

Sinopharm Group Co. Ltd.s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 7. Die grundlegenden Scores sind Audit: 6, Vorstand: 9, Shareholderrechte: 9, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.